Very few Cannabis-Based Medicinal Products are available via NHS prescription, there are currently only a handful of specific conditions with qualified CBPM treatments available. Other more traditional treatments are likely to be explored before the use of CBPMs is considered.
| Sativex | THC & CBD Spray | Treatment for Moderate to Severe Spasticity in Multiple Sclerosis Patients |
| Epidiolex | CBD Isolate Oil | Treatment for Seizures Associated with Lennox-Gastaut & Dravet Syndromes in Paediatric Patients (with Clobazam) |
| Nabilone | Synthetic THC | Add-on Treatment for Intractable Nausea/Vomiting for Chemotherapy Patients |
To the best of our understanding there are currently few prescriptions written for the medicines listed above. Outside of the specific medicines and their relevant use-cases listed, there is currently no further NHS accessibility to CBPMs.
National Health-Service FAQ: Cannabis-Based Medicinal Products
Guidance from National Institute for Health & Care Excellence: Cannabis-Based Medicinal Products.
There is currently a Medical Cannabis Access Bill being debated in parliament which could further CBPM access in the future. If you're currently considering the viability of medical cannabis for your health-care, only private medical clinics may be able to offer access to CBPMs as otherwise listed on this website.
Canada and many 
American states. Agree? Sign the 
Further National Health-Service Information on 